Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

NCT01257386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Ulcerative Colitis

Interventions

DRUG: Asacol®
DRUG: Mesalazine

Sponsor

Tillotts Pharma AG

Collaborators

[object Object]